Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review.
作者： Saeed K. Alzghari , Valerie S. Acuña
DOI: 10.1016/J.JCV.2020.104380
关键词:
摘要:
sci-hub.se 参考文章(15)
J. F. Enders, Infectious Diseases Society of America The Journal of Infectious Diseases. ,vol. 119, pp. 317- 318 ,(1969) , 10.1093/INFDIS/119.3.317
Fabrizio Cantini, Carlotta Nannini, Laura Niccoli, Linda Petrone, Giuseppe Ippolito, Delia Goletti, Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics. Mediators of Inflammation. ,vol. 2017, pp. 8909834- 8909834 ,(2017) , 10.1155/2017/8909834
Alexander Shimabukuro-Vornhagen, Philipp Gödel, Marion Subklewe, Hans Joachim Stemmler, Hans Anton Schlößer, Max Schlaak, Matthias Kochanek, Boris Böll, Michael S. von Bergwelt-Baildon, Cytokine release syndrome Journal for ImmunoTherapy of Cancer. ,vol. 6, pp. 56- 56 ,(2018) , 10.1186/S40425-018-0343-9
Zhe Xu, Lei Shi, Yijin Wang, Jiyuan Zhang, Lei Huang, Chao Zhang, Shuhong Liu, Peng Zhao, Hongxia Liu, Li Zhu, Yanhong Tai, Changqing Bai, Tingting Gao, Jinwen Song, Peng Xia, Jinghui Dong, Jingmin Zhao, Fu-Sheng Wang, Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet Respiratory Medicine. ,vol. 8, pp. 420- 422 ,(2020) , 10.1016/S2213-2600(20)30076-X
Zhongliang Wang, Bohan Yang, Qianwen Li, Lu Wen, Ruiguang Zhang, Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China. Clinical Infectious Diseases. ,vol. 71, pp. 769- 777 ,(2020) , 10.1093/CID/CIAA272
Antoney J. Ferrey, Grace Choi, Ramy M. Hanna, Yongen Chang, Ekamol Tantisattamo, Kaushik Ivaturi, Elisa Park, Lawrence Nguyen, Brian Wang, Sam Tonthat, Connie M. Rhee, Uttam Reddy, Wei Ling Lau, Susan S. Huang, Shruti Gohil, Alpesh N. Amin, Lanny Hsieh, Timmy T. Cheng, Richard A. Lee, Kamyar Kalantar-Zadeh, A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease. American Journal of Nephrology. ,vol. 51, pp. 337- 342 ,(2020) , 10.1159/000507417
Jing Yuan, Rougrong Zou, Lijiao Zeng, Shanglong Kou, Jianfeng Lan, Xiaohe Li, Yanhua Liang, Xiaoyan Ding, Guoyu Tan, Shenghong Tang, Lei Liu, Yingxia Liu, Yanchao Pan, Zhaoqin Wang, The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients. Inflammation Research. ,vol. 69, pp. 599- 606 ,(2020) , 10.1007/S00011-020-01342-0
J.-M. Michot, L. Albiges, N. Chaput, V. Saada, F. Pommeret, F. Griscelli, C. Balleyguier, B. Besse, A. Marabelle, F. Netzer, M. Merad, C. Robert, F. Barlesi, B. Gachot, A. Stoclin, Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report. Annals of Oncology. ,vol. 31, pp. 961- 964 ,(2020) , 10.1016/J.ANNONC.2020.03.300
Chi Zhang, Zhao Wu, Jia-Wen Li, Hong Zhao, Gui-Qiang Wang, Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. International Journal of Antimicrobial Agents. ,vol. 55, pp. 105954- 105954 ,(2020) , 10.1016/J.IJANTIMICAG.2020.105954
Carina Mihai, Rucsandra Dobrota, Maria Schröder, Alexandru Garaiman, Suzana Jordan, Mike Oliver Becker, Britta Maurer, Oliver Distler, COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD Annals of the Rheumatic Diseases. ,vol. 79, pp. 668- 669 ,(2020) , 10.1136/ANNRHEUMDIS-2020-217442